Child Psychiatry (F8-9)

Assessment In Child Psychiatry

Assessment in child psychiatry is a comprehensive, developmentally informed evaluation integrating clinical interviews with the child and caregivers, behavioral observations, standardized rating scales, and collateral information to diagnose and formulate mental health problems in children and adolescents.

2. Epidemiology and Context

3. General Principles of Assessment in Child Psychiatry

4. The Paediatric and Psychiatric History — Detailed Components

The pathway to care is the first question: "Why this child and why now?" [1] This immediately orients you — was the referral from a worried teacher who noticed social withdrawal? A frustrated parent who can't cope with aggression? A paediatrician who found no organic cause for recurrent abdominal pain?

4.2 Developmental History [2]

This is the single biggest difference from adult psychiatry. You need a full neurodevelopmental timeline:

5. Conducting the Interview — Techniques and Practical Approach

5.2 Interviewing the Child Alone [1]

This is an art. The general rules:

  1. Developmentally appropriate terms: simplify your terminology and avoid complex questions [1] — Instead of "Do you experience low mood?", try "Do you feel sad a lot?"
  2. Physical contact: be judicious, don't touch anybody for male doctors, especially cautious in patients with prior sexual abuse and physical abuse (damage rapport) [1] — Children who have been abused may interpret physical touch as threatening or, conversely, may show premature sexualising behaviour and develop inappropriate attachments if the doctor is too physically familiar. [1]
  3. Standardised behaviour rating scales: more objective, but diagnosis should still be based on structured interview and collateral information only (rating is for reference only) [1]

9. Physical Examination and Investigations

12. Formulation in Child Psychiatry

The formulation is the intellectual synthesis — the "so what?" of all the data you've gathered. It follows the same structure as adult psychiatry but with developmental emphasis:

13. Special Considerations for Assessment in the Hong Kong Context

14. Assessment of Specific Domains During Interview [1]

Differential Diagnosis in Child Psychiatric Assessment

When a child or adolescent is brought for psychiatric assessment, the presenting complaint is almost never pathognomonic for a single condition. Children present with behaviours (aggression, school refusal, poor concentration) and symptoms (sadness, worry, odd behaviour) that sit at the intersection of multiple possible diagnoses. Your job during the differential diagnosis process is to systematically consider, weigh, and discriminate between these possibilities.

The outcomes of history taking include: formulate and prioritize differential diagnoses; exclude the less likely differential diagnoses; ascertain severity of the problems and their impact on child and family. [4]

Key Cross-Cutting Principles for DDx in Children

References

[1] Senior notes: ryanho-psych.md (Chapter 12: Child Psychiatry, sections 12.1, 12.2, 12.3, 12.4, 12.5; Chapter 7: Mood Disorders; Chapter 8: Anxiety Disorders) [4] Lecture slides: CFB (PAE01) Paediatric history taking.pdf (p22, Box 2.2 Outcomes of History Taking) [5] Lecture slides: GC 163. I am a superman Bipolar disorder.pdf (p10, p12, p13)

Diagnostic Criteria, Diagnostic Algorithm, and Investigation Modalities

A. Diagnostic Criteria for Major Child Psychiatric Conditions

Below are the diagnostic criteria for the conditions most commonly encountered (and examined) in child psychiatry. I present both ICD (ICD-10/ICD-11, the system used in Hong Kong's Hospital Authority) and DSM-5 where relevant, highlighting key differences.


C. Assessment Protocol by Condition

For efficiency, here is a condition-specific assessment summary showing which tools and assessments are indicated:

D. Investigation Modalities — Physical Examination and Ancillary Tests

The purpose of investigations in child psychiatry is threefold:

  1. Exclude organic mimics of psychiatric symptoms
  2. Identify comorbid medical conditions that modify management
  3. Establish baseline before pharmacotherapy

Physical examination: only indicated if concern of presence of any genetic or medical disorders. [1] However, in practice, a baseline physical examination (including growth parameters, dysmorphology screen, and neurological examination) is prudent at first assessment.

References

[1] Senior notes: ryanho-psych.md (Chapter 12: Child Psychiatry sections 12.1–12.4; Chapter 2: Psychiatric Assessment sections 2.2.3–2.2.4; Chapter 1: Classification) [4] Lecture slides: CFB (PAE01) Paediatric history taking.pdf (p14–16, p22) [5] Lecture slides: GC 163. I am a superman Bipolar disorder.pdf (p10, p12, p13)

Management Algorithm and Treatment Modalities

Condition-Specific Management


1. ADHD Management

6. Bipolar Disorder in Children/Adolescents [5]

Outline of management [5]:

  • Correct diagnosis [5]
  • Illness acceptance and treatment adherence [5]
  • Family psychoeducation [5]
  • Pharmacological and psychosocial treatment [5]

Special Considerations

References

[1] Senior notes: ryanho-psych.md (Chapter 12: Child Psychiatry sections 12.1–12.5; Chapter 3: Treatment in Psychiatry sections 3.1–3.3; Chapter 7: Mood Disorders section on management) [5] Lecture slides: GC 163. I am a superman Bipolar disorder.pdf (p36, p37, p40, p41, p44, p46, p47, p64, p65) [6] Lecture slides: GC 164. I am depressed Mood disorders.pdf (p16, p18)

Complications and Prognosis of Child Psychiatric Conditions

A. Complications by Condition


1. ADHD — Complications and Course

2. ASD — Complications and Course

3. ODD/CD — Complications and Course

4. Childhood Anxiety Disorders — Complications and Course

B. Complications of Treatment (Iatrogenic)

These are equally important because they are preventable:

References

[1] Senior notes: ryanho-psych.md (Chapter 12: Child Psychiatry sections 12.1–12.5; Chapter 11: Intellectual Disability)

High Yield Summary

Assessment in Child Psychiatry — Key Principles:

  1. Multi-informant: Always interview parents, child (alone), and family together. Obtain school collateral.
  2. Developmentally contextualised: Compare symptoms to same-age, same-culture norms. Use age-appropriate interview techniques.
  3. Developmental history is essential: Full pregnancy/birth history, milestones (gross motor, fine motor, language, social), temperament.
  4. Systematic comorbidity screen: ADHD, ASD, ODD/CD, mood, anxiety, eating, sleeping, elimination — child psychiatric conditions rarely come alone.
  5. MSE is modified for children: Observe play, activity level, eye contact, separation behaviour; imaginary friends ≠ hallucinations.
  6. Rating scales supplement but do not replace clinical interview.
  7. Physical examination and investigations are essential to exclude organic mimics (hearing loss, epilepsy, thyroid, genetic syndromes).
  8. Risk assessment includes risk to self, to others, FROM others (abuse/neglect), and vulnerability.
  9. Formulation uses the 4 P's (predisposing, precipitating, perpetuating, protective) in a biopsychosocial framework.
  10. Ethical considerations: Consent requires parental involvement for < 18; Gillick competence for mature minors; confidentiality limits must be stated upfront; safeguarding is paramount.
  11. Hong Kong context: Academic pressure, stigma, MCHC → CAC → CAMHS referral pathways, domestic helper caregiving dynamics.

High Yield Summary

Differential Diagnosis in Child Psychiatric Assessment — Key Points:

  1. Always exclude organic causes first — hearing loss, epilepsy, thyroid, anaemia, genetic syndromes, sleep disorders, substance use.
  2. Compare to developmental norms — a behaviour is only a symptom if it exceeds what is expected for age and culture.
  3. Comorbidity is the rule — expect and diagnose multiple conditions when criteria are met (ADHD+ODD, depression+anxiety, ASD+ID).
  4. Inattentive child DDx: ADHD (pervasive, chronic) vs learning disorder (academic only) vs anxiety (worry-driven) vs depression (episodic) vs BAD (episodic with mood change) vs ASD (poor social skills, restricted interests) vs organic (hearing, epilepsy, OSA).
  5. Socially odd child DDx: ASD (qualitative social deficit + restricted behaviours) vs ID (proportional delay) vs language disorder (normal non-verbal communication) vs social anxiety (desires but fears interaction) vs schizophrenia prodrome (deterioration from baseline + psychotic features).
  6. Bipolar DDx pitfalls: Underdiagnosed (hypomania missed → labelled as MDD) AND overdiagnosed (incorrect use of "manic"/"躁"). Correct diagnosis delayed 5–7 years on average. Follow diagnostic criteria strictly; use collateral information.
  7. ADHD vs BAD: ADHD is chronic/trait-like; BAD is episodic. ADHD lacks grandiosity, ↓sleep need, flight of ideas.
  8. School refusal is a behaviour, not a diagnosis — systematically consider separation anxiety, social phobia, depression, bullying, ASD, specific learning disorder, or conduct-related truancy.
  9. Note the theme of anxiety to guide DDx (weight → eating disorder, illness → hypochondriasis, intrusive thoughts → OCD, separation → SAD/BPD, rejection → social phobia/avoidant PD).

High Yield Summary

Diagnostic Criteria, Algorithm, and Investigations in Child Psychiatry:

  1. Always use diagnostic criteria systematically — clinical impression alone leads to overdiagnosis and underdiagnosis. Up to 33% of BAD diagnoses could not be confirmed by structured interview.
  2. ASD: DSM-5 dyad = social-communication deficits (all 3 needed) + restricted/repetitive behaviours (≥ 2 of 4). Onset in early developmental period. Not better explained by ID alone.
  3. ADHD: ≥ 6/9 inattention and/or ≥ 6/9 hyperactivity-impulsivity symptoms. Present before age 12 (DSM-5) or 6 (ICD-10). Pervasive (≥ 2 settings). ICD-10 is stricter (requires both domains); DSM-5 allows inattentive-only and hyperactive-only presentations.
  4. Diagnostic algorithm: Multi-informant history → MSE → Developmental appropriateness filter → Standardised rating scales → Organic exclusion → Systematic criteria application → Formulation → MDT discussion.
  5. Assessment is MDT-based: Clinical interview (most important) + day hospital MDT assessment + IQ testing + educational assessment + OT + speech therapy + standardised instruments.
  6. Rating scales supplement but do not replace clinical interview.
  7. Key investigations to exclude organic mimics: Audiometry (hearing loss), EEG (epilepsy), TFTs (thyroid), CBP/ferritin (anaemia), MRI (structural lesions), genetic testing (fragile X, chromosomal microarray), anti-NMDA antibodies (in first-episode psychosis).
  8. Pre-medication baselines: Height/weight/BMI, BP/HR, ECG (if TCA/antipsychotic), CBP, RFT, LFT, TFTs, glucose, lipids, prolactin (if antipsychotic).
  9. ADOS-2 + ADI-R = gold standard ASD assessment tools. Conners/Vanderbilt with parent + teacher forms = key ADHD tools. K-SADS-PL = gold standard general child psychiatric diagnostic interview.
  10. Child-specific criteria modifications: Irritable mood can substitute for depressed mood in depression; ODD has three-factor structure predicting different outcomes; CD onset type (childhood vs adolescent) predicts prognosis.

High Yield Summary

Management in Child Psychiatry — Key Principles:

  1. Psychosocial interventions are generally first-line — especially PMT for ADHD/ODD/CD, CBT for anxiety/depression, and early intensive behavioural intervention for ASD.
  2. ADHD medications are the most effective psychotropics — effect sizes ~0.7–1.0. Methylphenidate is first-line stimulant. Stepped approach: mild → PMT only; moderate → medications + psychosocial; severe → medications as first choice.
  3. PMT is the mainstay for ODD/CD — based on social learning theory. "Catch your child being good" + systematic reinforcement/extinction.
  4. ASD has no cure — management is MDT-based. No medication treats core symptoms; risperidone/aripiprazole for irritability only. Beware polypharmacy.
  5. Fluoxetine is the only SSRI with robust evidence for paediatric depression. Black box warning for suicidal ideation → close monitoring in first 4 weeks. Benefits outweigh risks in moderate–severe depression.
  6. Bipolar management: Mania → lithium/valproate/atypical AP. Depression → lithium/lamotrigine/quetiapine. Prophylaxis → lithium (only drug to reduce suicide). Avoid antidepressants if possible.
  7. Lithium monitoring: Pre-treatment (RFT, TFT, ECG); on-treatment (Li levels, RFT, TFT Q6 months). Narrow therapeutic index. Trough level 12h post-dose.
  8. ECT is rarely used in children but is indicated for emergency, catatonia, and treatment-refractory cases.
  9. Always manage comorbidities — treat the ADHD in a child with ODD; treat the anxiety in a child with depression.
  10. Always involve the family and school — no child psychiatric intervention works in isolation.

High Yield Summary

Complications of Child Psychiatric Conditions — Key Points:

  1. ADHD: Age-dependent ↓ severity (hyperactivity > impulsivity > inattention), but ~50% retain criteria in adolescence and 40–60% have problems in adulthood. Key complications: academic failure, peer rejection, substance abuse, injuries, ODD/CD cascade, adult occupational failure and relationship problems. Treating ADHD with stimulants reduces later substance abuse risk.

  2. ASD: Core symptoms tend to improve but only a minority achieve independent adult living. Key complications: seizures (25%), psychiatric comorbidity (anxiety, depression, ADHD), autistic burnout from chronic masking, challenging behaviour, and exploitation.

  3. ODD/CD: Developmental cascade — ODD → CD → antisocial PD. Prognosis worse for early-onset (40% antisocial behaviour vs 20% in adolescent-onset). Complications include substance abuse, criminal behaviour, teenage pregnancy, educational failure.

  4. Childhood anxiety: 2/3 improve in 3–5 years, but 1/3 develop other anxiety disorders (heterotypic continuity). Untreated anxiety leads to academic underperformance, social isolation, adult anxiety/depression, and substance abuse.

  5. Youth depression: Episodic relapsing course. Key complications: suicide (leading cause of adolescent death), self-harm, substance abuse, recurrence, social harm. 25% may convert to bipolar disorder.

  6. Iatrogenic complications: Stimulant growth suppression, SSRI suicidality risk in first 2 weeks, antipsychotic metabolic syndrome and hyperprolactinaemia, lithium toxicity, valproate teratogenicity. Also: labelling effects, parental guilt, assessment delays.

  7. Comorbidity is itself a complication: Each comorbid condition worsens prognosis multiplicatively. Always screen for and treat comorbidities.

On this page

No Headings